E2 - Dihydrolipoamide S-Acetyltransferase

title: E2 - Dihydrolipoamide S-Acetyltransferase
category: protein

E2 — Dihydrolipoamide S-Acetyltransferase

Introduction

E2 Dihydrolipoamide S Acetyltransferase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@blass2000]

title: E2 - Dihydrolipoamide S-Acetyltransferase
category: protein

E2 — Dihydrolipoamide S-Acetyltransferase

Introduction

E2 Dihydrolipoamide S Acetyltransferase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@blass2000]

<div class="infobox infobox-protein"> [@salker2012]
<table> [@liu2008]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Dihydrolipoamide S-Acetyltransferase</th></tr> [@klun2019]
<tr><td><strong>Protein Name</strong></td><td>E2 (DLAT)</td></tr> [@xie2011]
<tr><td><strong>Gene</strong></td><td>[DLAT](/genes/dlat)</td></tr> [@sheu2019]
<tr><td><strong>UniProt ID</strong></td><td>[P10515](https://www.uniprot.org/uniprot/P10515)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>1QAA, 2D1J, 3l1c</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>70 kDa (670 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondrial matrix</td></tr>
<tr><td><strong>Protein Family</strong></td><td>2-oxoacid dehydrogenase complex family</td></tr>
<tr><td><strong>Enzyme Commission</strong></td><td>EC 2.3.1.12</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">46 edges</a></td>
</tr>
</table>
</div>

Overview

Dihydrolipoamide S-Acetyltransferase (DLAT, also known as E2 component) is the catalytic core enzyme of the [pyruvate dehydrogenase complex (PDC)](/mechanisms/pyruvate-dehydrogenase-complex), one of the most important metabolic enzyme complexes in cellular metabolism. DLAT catalyzes the transfer of the acetyl group from acetyl-dihydrolipoamide to [coenzyme A (CoA)](/entities/coenzyme-a), forming [acetyl-CoA](/entities/acetyl-coa) and regenerating dihydrolipoamide. This reaction is a critical step linking [glycolysis](/mechanisms/glycolysis) to the [citric acid cycle (TCA cycle)](/mechanisms/citric-acid-cycle), making DLAT essential for cellular energy production through [oxidative phosphorylation](/mechanisms/oxidative-stress-neurodegeneration).

The pyruvate dehydrogenase complex is a large multienzyme assembly consisting of multiple copies of three enzymatic components: E1 (pyruvate dehydrogenase, encoded by [PDHA1](/genes/pdha1)/[PDHA2](/genes/pdha2)), E2 (DLAT), and E3 (dihydrolipoamide dehydrogenase, encoded by [DLD](/genes/dld)). DLAT forms the structural and catalytic core of this complex, organizing the other components into a precise supramolecular structure that ensures efficient substrate channeling and metabolic regulation.

Structure and Architecture

Overall Structure

DLAT adopts a distinctive cubic symmetry, forming a 24-mer core structure that represents one of the largest known enzymatic assemblies in cellular metabolism. The protein consists of three distinct domains connected by flexible linker regions:

Catalytic Mechanism

The catalytic mechanism of DLAT involves a ping-pong bi-bi ordered ternary complex mechanism:

The 24-mer structure allows multiple simultaneous reactions, dramatically increasing the overall throughput of the complex. Each vertex of the cube can catalyze the reaction independently, providing a remarkable example of evolutionary optimization of metabolic efficiency.

Biological Function

Role in Cellular Metabolism

DLAT is essential for aerobic energy metabolism in all eukaryotes and many prokaryotes. The pyruvate dehydrogenase complex sits at the crossroads of carbohydrate metabolism, converting pyruvate (the end product of glycolysis) into acetyl-CoA, the fuel for the TCA cycle. This conversion is irreversible and represents a major regulatory point in cellular metabolism.

Key metabolic functions include:

• Glucose oxidation: PDH complex links glycolysis to the TCA cycle by converting pyruvate to acetyl-CoA
• ATP production: The acetyl-CoA generated feeds into the TCA cycle, producing NADH and FADH2 for oxidative phosphorylation
• Biosynthetic precursor: Acetyl-CoA is also used for fatty acid synthesis and cholesterol biosynthesis
• Acetyl-CoA homeostasis: The complex helps maintain cellular acetyl-CoA levels for various biosynthetic and regulatory purposes

Regulation

DLAT activity is tightly regulated through multiple mechanisms:

Role in Neurodegenerative Diseases

Alzheimer's Disease

DLAT has emerged as a significant player in [Alzheimer's disease (AD)](/diseases/alzheimers-disease) pathogenesis:

Metabolic dysfunction: Multiple studies have documented reduced DLAT expression and activity in [AD brain tissue](/brain-regions/hippocampus), particularly in the [hippocampus](/brain-regions/hippocampus) and [cerebral cortex](/brain-regions/cortex). This reduction contributes to cerebral glucose hypometabolism, a hallmark of AD that precedes clinical symptoms by decades.

Mechanisms linking DLAT to AD:

• [Amyloid-beta](/proteins/amyloid-beta-protein) oligomers directly inhibit PDH activity, reducing acetyl-CoA production
• [Tau pathology](/proteins/tau) is associated with impaired mitochondrial function and reduced DLAT activity
• Reduced glucose metabolism in AD brain correlates with decreased PDH complex activity
• The resulting energy deficit contributes to synaptic dysfunction and neuronal loss

• Thiamine (vitamin B1) supplementation has been explored to enhance PDH activity in AD
• Dichloroacetate (DCA), a PDH kinase inhibitor, has been tested in preclinical AD models
• Gene therapy approaches to enhance DLAT expression are under investigation

Parkinson's Disease

DLAT alterations are also relevant to [Parkinson's disease (PD)](/diseases/parkinsons-disease):

• Mitochondrial dysfunction is a central feature of PD pathogenesis
• PDH complex activity is reduced in [substantia nigra](/brain-regions/substantia-nigra) [neurons](/entities/neurons) in PD
• Complex I deficiency in PD may be linked to broader mitochondrial dysfunction including DLAT
• [Alpha-synuclein](/proteins/alpha-synuclein) aggregation impairs mitochondrial function

Other Neurodegenerative Conditions

• MELAS syndrome: Caused by mutations in mitochondrial DNA affecting PDC function
• PDH deficiency: Inherited disorders causing severe encephalopathy
• Hypoxia: Ischemic conditions impair PDH activity, relevant to vascular dementia

Clinical Significance

Biomarker Potential

DLAT and other PDC components have been studied as biomarkers:

• Decreased PDH activity in peripheral blood mononuclear cells correlates with cognitive decline
• DLAT autoantibodies have been detected in some autoimmune conditions
• Cerebrospinal fluid DLAT levels may reflect neuronal metabolic status

Therapeutic Targeting

Several therapeutic strategies target DLAT/PDH:

Research Methods

Experimental Approaches

• Enzyme assays: Spectrophotometric measurement of acetyl-CoA production
• Western blotting: Protein expression analysis
• Immunohistochemistry: Localization in brain tissue
• Proteomics: Global protein expression studies
• Metabolomics: Assessment of metabolic fluxes
• Crystal structure: X-ray crystallography of DLAT domains

Model Systems

• Cell cultures: Neuronal cell lines, primary neurons
• Animal models: Transgenic mice, knockout models
• Post-mortem brain tissue: Human brain banks
• Induced pluripotent stem cells (iPSCs): Patient-derived neurons

Summary

DLAT (dihydrolipoamide S-acetyltransferase) is the catalytic core of the pyruvate dehydrogenase complex, essential for converting pyruvate to acetyl-CoA and linking glycolysis to oxidative metabolism. In neurodegenerative diseases, particularly Alzheimer's disease, DLAT dysfunction contributes to cerebral hypometabolism and neuronal loss. Understanding DLAT regulation and developing therapeutic strategies to maintain its function represents an important frontier in treating neurodegenerative conditions characterized by metabolic deficits.

Background

The study of E2 Dihydrolipoamide S Acetyltransferase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

See Also

• Gene: DLAT
• Pyruvate Dehydrogenase Complex
• Mitochondrial Metabolism
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-disease-mechanisms)
• Cerebral Glucose Metabolism
• Oxidative Phosphorylation